ALDH1A1 and Oct-4 gene expression was analyzed because ALDH1A1 is now being widely studied as a prostate cancer stem cell marker [29–31] and Oct-4 is an embryonic stem cell marker [32–34]. This evidence concerns the gene POU5F1 and prostate carcinoma.